Patents by Inventor Lingbing Kong

Lingbing Kong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240361513
    Abstract: An electronic device is provided, including a housing, a circuit board, an infrared generator, and a light guide member. The housing is provided with a light-transmitting hole and an accommodating cavity for accommodating the circuit board, the infrared generator, and the light guide member. The infrared generator is mounted on the circuit board. The light guide member includes a light incident surface and a light exit surface. The light guide member is at least partially arranged in the light-transmitting hole. The light incident surface and the light exit surface are arranged in a staggered manner. The light incident surface is arranged corresponding to the infrared generator, and the light incident surface is an aspherical curved surface. Infrared light emitted by the infrared generator emits outward through the light guide member.
    Type: Application
    Filed: July 11, 2024
    Publication date: October 31, 2024
    Applicant: VIVO MOBILE COMMUNICATION CO., LTD.
    Inventors: Lingbing KONG, Qinming CAI
  • Patent number: 9963518
    Abstract: Compounds which inhibit Wza-mcdiated polysaccharide transport are useful in the prevention or treatment of bacterial infection, in particular of E. coli infection. The compounds are typically cyclic oligosaccharides such as cyclodextrins, which bear positively charged functional groups at the primary carbon position.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: May 8, 2018
    Assignee: Oxford University Innovation Limited
    Inventors: Lingbing Kong, Benjamin G. Davis, Hagan Bayley
  • Publication number: 20140296180
    Abstract: Compounds which inhibit Wza-mcdiated polysaccharide transport are useful in the prevention or treatment of bacterial infection, in particular of E. coli infection. The compounds are typically cyclic oligosaccharides such as cyclodextrins, which bear positively charged functional groups at the primary carbon position.
    Type: Application
    Filed: August 20, 2012
    Publication date: October 2, 2014
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Lingbing Kong, Benjamin G. Davis, Hagan Bayley